Correlia Biosystems

Correlia Biosystems has developed an ultra-efficient sample analysis platform for animal research, drug development & diagnostics. The platform automates protein detection with dramatic/measured breakthroughs in speed, sample miniaturization, and efficiency (up to 7200x more data per hour).

Correlia Biosystems is active in the health space based in Berkeley, CA, USA.

Profile

Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules.

Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.

Correlia Biosystems is positioned in health, a segment that rewards a clear, focused offering.

Its base of operations is Berkeley, CA, USA.

Directory data places it at the Winter 2018 stage.

Recorded headcount: 16 employees.

Website: www.correliabio.com